SEMA3E and neoplasm: The elevated expression of another secreted semaphorin, Sema3E, has been associated with high-grade ovarian endometrioid carcinomas, but not other ovarian epithelial tumors, and found to promote tumor cell invasiveness via its specific receptor PlexinD1 52.